Stocks to be monitored: Ltimindtree, Enterprise Brigade, Bharti Airtel, Vodafone Idea and more

Bharti Airtel, Vodafone Idea | The basis of India telecommunications subscribers increased modestly in August 2025, with JIO reliance, according to data from the Telecom Regulatory Authority of India (Trai). JIO added 19.5 Lakh users during the month, which was higher than 4.83 Lakh added in July. The Bharti Airtel user base increased by 4.96 Lakh, slightly up compared to 4.94 Lakh in July, while Vodafone Idea continued to lose customers, clearing 3.1 Lakh subscribers against 3.5 Lakh the previous month.

Dilip Buildcon | The infrastructure company said that the company, through its DBL-APMPL joint venture (DBL 74% and APMPL 26%), received an acceptance letter (LOA) to develop a solar solar solar electricity project (PV) of 100 MW in captive mode. The project is to provide power to Madhya Pradesh Jal Nigam (MPJNM) for a period of 25 years from the date of commissioning. The project, awarded by MPJNM, is domestic in nature and will be developed within the framework of a general contract.

Hcltech | The IT services company said that it had joined MIT Media Lab, a worldwide research and innovation ecosystem at the Massachusetts Institute of Technology (MIT), to collaborate in research on new generation artificial intelligence (IA). The partnership marks an important step in HCLTECH’s commitment to shape the future of AI and to lead to breakthroughs in emerging technological fields, including quantum computers, thanks to collaborative innovation.

Zydus Lifescienceces | The company said on Monday that it had received an opinion of compliance (NOC) of Health Canada for its generic liothyronine tablets in 5 mcg and 25 mcg. Liothyronine, a synthetic form of T3 thyroid hormone (triiodothyronin), is mainly used to treat hypothyroidism. The tablets will be made in the installation of Zydus Ahmedabad Sez. The product made annual sales of $ 10.9 million Canadian dollars in Canada, according to IQVIA MAT data for June 2025.

Metropolis Healthcare | The company has recorded consolidated income growth of 23% over the year for the second quarter of 26, driven by preventive health assessments and well-being services. Basic diagnoses have gone from the profitability threshold to Q4FY25 to a high figure in Q2FY26. DAPIC (DEHRADUN) and scientific pathology (AGRA) surpassed the average margin of the company. The well-being and truhealth specialty segments increased by 25% and 36% in annual shift, respectively. B2C income increased by 16%, while B2B income increased by 34%. The company remains without debt with a net cash excess of 55 sterling books.

Bank of India | The public bank declared an annual growth of 11.8% in its global activities, which increased to 15.61,888 sterling books on September 30, 2025, against 13.97,100 crores a year earlier, according to the provisional financial results of the Bank for the second quarter of the FY26. Global deposits increased by 10.08% in annual sliding to 8.53,301 crosses against 7.75,181 crosses a year earlier, while global advances increased by 13.94% to 7 08,587 crore of ₹ against 6,2,1919 crore.